133 related articles for article (PubMed ID: 31089638)
1. New geldanamycin derivatives with anti Hsp properties by mutasynthesis.
Hermane J; Eichner S; Mancuso L; Schröder B; Sasse F; Zeilinger C; Kirschning A
Org Biomol Chem; 2019 May; 17(21):5269-5278. PubMed ID: 31089638
[TBL] [Abstract][Full Text] [Related]
2. New, non-quinone fluorogeldanamycin derivatives strongly inhibit Hsp90.
Hermane J; Bułyszko I; Eichner S; Sasse F; Collisi W; Poso A; Schax E; Walter JG; Scheper T; Kock K; Herrmann C; Aliuos P; Reuter G; Zeilinger C; Kirschning A
Chembiochem; 2015 Jan; 16(2):302-11. PubMed ID: 25572106
[TBL] [Abstract][Full Text] [Related]
3. 19-[(1'S,4'R)-4'-Hydroxy-1'-methoxy-2'-oxopentyl]geldanamycin, a natural geldanamycin analogue from Streptomyces hygroscopicus 17997.
Li S; Ni S; Wu L; Li L; Jiang B; Wang H; Sun G; Gan M; Li J; He W; Lin L; Wang Y; Bai S; Si S
J Nat Prod; 2013 May; 76(5):969-73. PubMed ID: 23656556
[TBL] [Abstract][Full Text] [Related]
4. Bioreduction of aryl azides during mutasynthesis of new ansamitocins.
Mancuso L; Jürjens G; Hermane J; Harmrolfs K; Eichner S; Fohrer J; Collisi W; Sasse F; Kirschning A
Org Lett; 2013 Sep; 15(17):4442-5. PubMed ID: 23981134
[TBL] [Abstract][Full Text] [Related]
5. New geldanamycin analogs from Streptomyces hygroscopicus.
Wu CZ; Jang JH; Ahn JS; Hong YS
J Microbiol Biotechnol; 2012 Nov; 22(11):1478-81. PubMed ID: 23124337
[TBL] [Abstract][Full Text] [Related]
6. New C-19-modified geldanamycin derivatives: synthesis, antitumor activities, and physical properties study.
Liu YF; Zhong JJ; Lin L; Liu JJ; Wang YG; He WQ; Yang ZY
J Asian Nat Prod Res; 2016 Aug; 18(8):752-64. PubMed ID: 26988280
[TBL] [Abstract][Full Text] [Related]
7. Heat Shock Proteins Revisited: Using a Mutasynthetically Generated Reblastatin Library to Compare the Inhibition of Human and Leishmania Hsp90s.
Mohammadi-Ostad-Kalayeh S; Stahl F; Scheper T; Kock K; Herrmann C; Heleno Batista FA; Borges JC; Sasse F; Eichner S; Ongouta J; Zeilinger C; Kirschning A
Chembiochem; 2018 Mar; 19(6):562-574. PubMed ID: 29265716
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites.
Lee K; Ryu JS; Jin Y; Kim W; Kaur N; Chung SJ; Jeon YJ; Park JT; Bang JS; Lee HS; Kim TY; Lee JJ; Hong YS
Org Biomol Chem; 2008 Jan; 6(2):340-8. PubMed ID: 18175003
[TBL] [Abstract][Full Text] [Related]
9. New non-quinone geldanamycin analogs from genetically engineered Streptomyces hygroscopicus.
Wu CZ; Moon AN; Jang JH; Lee D; Kang SY; Park JT; Ahn JS; Hwang BY; Kim YH; Lee HS; Hong YS
J Antibiot (Tokyo); 2011 Jun; 64(6):461-3. PubMed ID: 21448187
[No Abstract] [Full Text] [Related]
10. New, highly active nonbenzoquinone geldanamycin derivatives by using mutasynthesis.
Eichner S; Floss HG; Sasse F; Kirschning A
Chembiochem; 2009 Jul; 10(11):1801-5. PubMed ID: 19554593
[No Abstract] [Full Text] [Related]
11. Pseudoverticin B, a novel geldanamycin analog obtained as new cell cycle inhibitor from Streptomyces pseudoverticillus YN17707.
Li WX; Han B; Cui CB
J Asian Nat Prod Res; 2016 Jul; 18(7):705-10. PubMed ID: 26813156
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel 17-phenylethylaminegeldanamycin derivatives as potent Hsp90 inhibitors.
Li Z; Jia L; Wang J; Wu X; Shi G; Lu C; Shen Y
Chem Biol Drug Des; 2015 Feb; 85(2):181-8. PubMed ID: 24903735
[TBL] [Abstract][Full Text] [Related]
13. A unique macrolactam derivative via a [4+6]-cycloaddition from Streptomyces niveus.
Li L; Cai Y; Jiang Y; Liu J; Ma J; Yuan C; Mu Y; Han L; Huang X
Bioorg Med Chem Lett; 2016 Mar; 26(6):1599-1604. PubMed ID: 26874404
[TBL] [Abstract][Full Text] [Related]
14. Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
Onodera H; Kaneko M; Takahashi Y; Uochi Y; Funahashi J; Nakashima T; Soga S; Suzuki M; Ikeda S; Yamashita Y; Rahayu ES; Kanda Y; Ichimura M
Bioorg Med Chem Lett; 2008 Mar; 18(5):1588-91. PubMed ID: 18243703
[TBL] [Abstract][Full Text] [Related]
15. Identification of 6-demethoxy-6-methylgeldanamycin and its implication of geldanamycin biosynthesis.
Ni S; Jiang B; Wu L; Wang Y; Zhou H; He W; Wang H; Zhu J; Li S; Li T; Zhang K
J Antibiot (Tokyo); 2014 Feb; 67(2):183-5. PubMed ID: 24105607
[No Abstract] [Full Text] [Related]
16. A pair of sulfur-containing geldanamycin analogs, 19-S-methylgeldanamycin and 4,5-dihydro- 19-S-methylgeldanamycin, from Streptomyces hygroscopicus 17997.
Liu X; Li J; Ni S; Wu L; Wang H; Lin L; He W; Wang Y
J Antibiot (Tokyo); 2011 Jul; 64(7):519-22. PubMed ID: 21559026
[No Abstract] [Full Text] [Related]
17. Design, synthesis, and structure--activity relationships for chimeric inhibitors of Hsp90.
Shen G; Wang M; Welch TR; Blagg BS
J Org Chem; 2006 Sep; 71(20):7618-31. PubMed ID: 16995666
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a cytotoxic ansamycin hybrid.
Jürjens G; Kirschning A
Org Lett; 2014 Jun; 16(11):3000-3. PubMed ID: 24874463
[TBL] [Abstract][Full Text] [Related]
19. Microarray-based screening of heat shock protein inhibitors.
Schax E; Walter JG; Märzhäuser H; Stahl F; Scheper T; Agard DA; Eichner S; Kirschning A; Zeilinger C
J Biotechnol; 2014 Jun; 180():1-9. PubMed ID: 24667540
[TBL] [Abstract][Full Text] [Related]
20. The interplay between mutasynthesis and semisynthesis: generation and evaluation of an ansamitocin library.
Eichner S; Knobloch T; Floss HG; Fohrer J; Harmrolfs K; Hermane J; Schulz A; Sasse F; Spiteller P; Taft F; Kirschning A
Angew Chem Int Ed Engl; 2012 Jan; 51(3):752-7. PubMed ID: 22135226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
